(redirected from angiotensin-converting enzyme inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
See: item, unit
References in periodicals archive ?
National patterns of angiotensin-converting enzyme inhibitor use in congestive failure.
Cocoa--but not tea--consumption appears to be associated with blood pressure reductions comparable with those achieved with a [beta]-blocker or an angiotensin-converting enzyme inhibitor.
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Patients are not fully protected by a statin, aspirin, clopidogrel, an angiotensin-converting enzyme inhibitor, and a [beta]-blocker.
today announced that administration of FG-3019 alone, or in combination with angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB), was significantly better in preventing and reversing arterial stiffness than ACEi or ARB therapy alone in preclinical models of diabetes.
We previously reported that the combined treatment of vitamin K2 (VK) and angiotensin-converting enzyme inhibitor (ACE-I) significantly suppressed the experimental hepatocarcinogenesis.
1) Angiotensin-converting enzyme inhibitor (ACEI) therapy should be initiated in high-risk patients for prevention of stroke, myocardial infarction and death.
The Scottish Medicines Consortium (SMC) announced today that Amias (candesartan cilexetil), an angiotensin-receptor blocker (ARB), currently used in the treatment of essential hypertension, has been accepted for use in Scotland for the treatment of patients with chronic heart failure (CHF) and left ventricular systolic dysfunction (LVSD; LV ejection fraction less than or equal to 40%) as add-on therapy to an angiotensin-converting enzyme inhibitor (ACEi) or for those patients unable to tolerate an ACEi.
The two heart attack medications evaluated were angiotensin-converting enzyme inhibitor (ACEI), a drug used to reduce elevated blood pressure; and HMG-CoA reductase inhibitors, a group of prescription drugs effective in lowering cholesterol.
This randomized, double-blind, active-controlled clinical trial assessed efficacy of first-step antihypertensive drug therapy with calcium channel blocker or angiotensin-converting enzyme inhibitor compared with thiazide-type diuretic in DM, IFG and normoglycemic (NG) persons.
All were being seen in a heart failure clinic, and 90% were taking an angiotensin-converting enzyme inhibitor, 90% were on a [beta]-blocker, and 93% were on a diuretic.

Full browser ?